Jan 10,2023

New Study Combines AI And Multiomics Analysis To Understand Cancer Resistance Mechanisms

Baylor Scott and White Health and the Translational Genomics Research Institute (TGen) have announced a joint research project aimed at analyzing cancer resistance mechanisms using multiomics technologies, in collaboration with OncoHost, an Israeli start-up.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 11,2023

Paige Collaborates with Microsoft to Transform Cancer Diagnosis and Treatment with the Use of Pathology AI

Paige has teamed up with Microsoft to utilize artificial intelligence (AI) to analyze digital pathology images and develop a new set of clinical applications and computational biomarkers. This collaboration will help improve cancer diagnosis and patient care. Furthermore, Microsoft is also making a strategic investment in Paige to accelerate the development and deployment of life-saving AI diagnostics. Paige will use Microsoft Azure as its cloud provider for the Paige Platform, a comprehensive solution to power a lab’s digital pathology workflow that consists of data management, cloud storage options and FullFocus®, an FDA-cleared whole-slide image viewer. As part of this collaboration, Paige will become a Microsoft Cloud for Healthcare partner and enable Microsoft to enhance its own offerings for healthcare customers.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 12,2023

Key Takeaways from ASH 2022: Real-World Data Gets Down to Business

Real-world data is an indispensable tool for therapeutic development and clinical research, as revealed in the 2021 annual meeting of the American Society of Hematology. In this context, COTA contributed research on chronic lymphocytic leukemia and took part in the discussion.

#rwd

#big data

View Analyst & Ambassador Comments
Go to original news
Jan 12,2023

OncoHost Wins 2023 BIG Innovation Award for PROphet® Platform

OncoHost, a leading provider of next-generation precision oncology solutions, announced that its PROphet® platform won the healthcare category of the 2023 BIG Innovation Awards, presented by the Business Intelligence Group (BIG).

PRODUCT

#platform

#ml

View Analyst & Ambassador Comments
Go to original news
Jan 12,2023

Effects of virtual reality on physical, cognitive, and psychological outcomes in cancer rehabilitation: a systematic review and meta-analysis

The objective of this study was to comprehensively review the existing evidence on the effects of virtual reality (VR) in cancer rehabilitation, particularly in physical, cognitive, and psychological outcomes. The findings demonstrate that VR has promising effects in improving various aspects of cancer patients. Therefore, integrating VR into cancer rehabilitation programs can be a useful approach to alleviate functional limitations and impairments.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 16,2023

Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study

A recent study involved the development and pilot testing of a personalized eHealth intervention to assist female breast cancer survivors in managing persistent pain after surgery. The research aimed to assess the acceptability, comprehensibility, and efficacy of the intervention. The study found that a personalized eHealth intervention containing a pain science education program and self-management support strategies was effective in managing persistent pain after breast cancer surgery. A controlled clinical trial is recommended to determine its effectiveness, and a full process evaluation is needed.

CLINICAL STUDY

#mobile app

#telehealth

View Analyst & Ambassador Comments
Go to original news
Jan 17,2023

PAVmed and Lucid Diagnostics Provide Strategic Business Update

PAVmed Inc., a medical technology company focused on medical devices, diagnostics, and digital health, as well as its majority-owned subsidiaries, Lucid Diagnostics and Veris Health, have released a strategic business update outlining their near-term priorities and resource allocation. The companies intend to focus on Lucid and Veris Health's commercialization efforts in the short term, and have implemented measures such as a 20% workforce reduction and product portfolio streamlining to reduce quarterly cash burn by at least 25%.

#telehealth

#platform

View Analyst & Ambassador Comments
Go to original news
Jan 19,2023

Top Artificial Intelligence Companies In Healthcare To Keep An Eye On

The medical AI industry is rapidly evolving, with an increasing number of companies seeking to revolutionize healthcare using artificial intelligence. It can be difficult to keep track of the most promising ones due to the rapid turnover of such companies. However, there are several significant players in the field, ranging from startups to tech giants, that should be closely monitored for their potential impact on healthcare. Among the companies to watch are Behold.ai, Oxipit, and Turbine, which all have a focus on Oncology.

#ai/software

#rwd

View Analyst & Ambassador Comments
Go to original news
Jan 24,2023

How Real-World Data Helps Explore Alternative Dosing for Colorectal, Pancreatic Cancer Therapy

A joint effort between MedStar Georgetown Lombardi Comprehensive Cancer Center and COTA has demonstrated the feasibility of a patient-oriented dosing schedule for Stage 4 CRC/PC or locally advanced PC. This partnership showcases the contribution of real-world data to clinical research, which can provide insights into care that is currently being administered in clinical settings and help address critical questions.

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

What Makes a Fit-for-Purpose Database for Clinical Oncology Research?

A fit-for-purpose database includes key variables, reliable and accurate data, and representative samples that can be used to draw meaningful conclusions. lthough Real-World Data (RWD) can be extremely beneficial in supporting clinical oncology research, selecting the appropriate data is crucial. The keys to finding the right fit-for-purpose database include relevance, reliability, integrity, and bias.

#rwd

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY